Benzinga | Nov 4, 2020 07:10AM EST

Pieris Pharmaceuticals Q3 EPS $(0.26) Misses $(0.13) Estimate

Pieris Pharmaceuticals (NASDAQ:PIRS) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.13) by 100 percent. This is a 420 percent decrease over losses of $(0.05) per share from the same period last year.